Lansoprazole-induced subacute cutaneous lupus erythematosus.
Panting
K J
KJ
Pinto
M
M
Ellison
J
J
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000009:adverse effects*; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D005260:Female; D005759:Gastroenteritis / Q000188:drug therapy*; D006801:Humans; D064747:Lansoprazole; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced*; D008875:Middle Aged; D013472:Sunlight / Q000009:adverse effects
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D004791:Enzyme Inhibitors; D064747:Lansoprazole